The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia |
Boston Children’s Hospital / Vijay Sankaran, MD/PhD |
Innovation Grants |
2024 |
Massachusetts |
Illuminating Choroid Plexus Carcinoma Vascularization in Real Time |
Boston Children’s Hospital / Maria Lehtinen, PhD |
Innovation Grants |
2024 |
Massachusetts |
Targeting of a putative unresolved wound healing process in childhood ependymoma |
University of Colorado Denver / Nicholas Foreman, MD |
Innovation Grants |
2024 |
Colorado |
Pathological Condensates and Transcription Dysregulation in Rhabdomyosarcoma at Single-Molecule Resolution |
California Institute of Technology / Shasha Chong, PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Direct targeting of oncoprotein assembly using mimetic peptide interference |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Innovation Grants |
2024 |
New York |
Utilizing chromatin directed inhibitors to regulate gene expression in Ewing sarcoma for therapeutic benefit |
University of North Carolina / Justin Sperlazza, MD/PhD |
Young Investigator Grants |
2024 |
North Carolina |
MYCN-induced molecular clock disruption and metabolic rewiring drive neuroblastoma |
Baylor College of Medicine / Lingzhi Li, PhD |
Young Investigator Grants |
2024 |
Texas |